WHO Scholar

Dear colleagues,

In order to define a roadmap to support countries to develop and implement strategies for integrating heat-sensitive products into the vaccine cold chain, WHO is launching a consultation with TechNet members. The aim of this consultation is to contribute to defining the interventions to be carried out and the resources to be mobilized at country and global level.

Specifically, WHO would like to identify the lessons learned by countries that are already implementing a practice of Oxytocin or Insulin in the vaccine cold chain; identify the factors facilitating and limiting this integration and define at which segments of the supply chain integration should take place. Here are some of the questions WHO would like to pose to the TechNet21 community:

What has been your experiences when integrating oxytocin and insulin (or other non-EPI vaccines product) in your country cold chain system? What were the key reasons for doing so, the decision-making process and what things worked and what didn’t?

What are the most critical factors limiting the integration of Oxytocin or Insulin into the vaccine cold chain in countries that have not yet done so? And what are the top 3 factors that would facilitate this integration?

Where integration is more appropriate: What segments of the supply chain could most benefit from integration? At what level of the supply chain should integration occur (national, sub-national and service levels)? For what function of the supply chain should integration occur (planning, storage, distribution, handling, and management, information, cold chain equipment temperature and performance monitoring, and management)?”

Could you please reply here:  https://www.technet-21.org/en/community/discussions/integration-of-temperature-sensitive-pharmaceuticals-in-the-vaccine-cold-chain

We would appreciate any feedback, even if short.

Thank you for expressing your view and experience!

Dear colleagues, 
 
You are invited to the second webinar series on Why Gender Matters for Immunization: IA2030. 
 
The Immunization Agenda 2030 envisions a world where everyone, everywhere, at every age, fully benefits from vaccines to improve health and well-being. Gender-related barriers and gender inequality can prevent people, both male and female, from getting vaccinated. The goal of gender equality is to ensure that everyone has the same chances and opportunities to access and benefit from immunization services.
 
Building upon the first webinar series organized in 2023 ( https://www.technet-21.org/en/topics/programme-management/gender-and-immunization), this second series of webinars, based on the joint WHO, UNICEF and Gavi guidance document Why Gender Matters: IA2030 ( https://www.who.int/publications/i/item/9789240033948), aims to further improve awareness and understanding of how gender-related barriers impact immunization. The series will focus on examples and best practices of gender-responsive programming to improve coverage and equity from around the world. 
 
The webinar series will run across 5 sessions, on Thursdays from 15-16h (CET): 7 March, 4 April, 9 May, 6 June, and 11 July. Additional information available in the poster attached.
 
Sessions will be in English, with simultaneous translation into French.
 
Registration available here:  https://who.zoom.us/webinar/register/WN_ww9PgxybTcWv-OkPZNE43A
 
We hope you can join us and please share this information widely across your networks!